1 to 1.5 million children in India are living with epilepsy, which is a brain condition that is caused by unusual electrical activity. The symptoms of epilepsy include brief staring spells, confusion, ...

Findings showed there was a median reduction of 86% in countable motor seizure frequency compared with baseline in the seizure cohort. The Food and Drug Administration (FDA) has granted Breakthrough ...

Please provide your email address to receive an email when new articles are posted on . Allowing clinicians to prescribe a larger supply of antiseizure drugs to veterans with epilepsy improved ...

Longboard Pharmaceuticals LBPH gained 14.4% on Jul 1 after it announced that the FDA has granted Breakthrough Therapy designation for its investigational drug, bexicaserin, to treat seizures ...

In a world-first breakthrough, researchers have used an epilepsy-like disease model in a laboratory dish and showed that improved information processing and neural function can be achieved using a ...

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) shares climbed 4% on Monday after the company announced that the U.S. Food and Drug Administration had granted Breakthrough Therapy Designation to ...

Praxis Precision Medicines said federal regulators have granted their breakthrough therapy designation, or BTD, to its seizure treatment, relutrigine. The clinical-stage biopharmaceutical company said ...

Detailed price information for Praxis Precision Medicines Inc (PRAX-Q) from The Globe and Mail including charting and trades.

Your child’s brain is an incredible electrical system. Billions of neurons firing in perfect harmony to create thoughts, movements, feelings, and memories. But sometimes, that delicate electrical ...

A drug that has long been used to treat seizures has shown promise as a potential means of Alzheimer's prevention, a new study suggests. The anti-seizure medication, levetiracetam, was first approved ...